Dementia and Alzheimer's Disease

National Plan to Address Alzheimer's Disease: 2018 Update. Strategy 2.G: Advance Coordinated and Integrated Health and Long-Term Services and Supports for Individuals Living with Alzheimer's Disease and Related Dementias

Coordinating the care received by people with AD/ADRD in different settings by different providers can help reduce duplication and errors and improve outcomes. Despite a general consensus that care coordination is important, more research is needed to determine how best to provide such care in a high-quality and cost-efficient manner. The actions

National Plan to Address Alzheimer's Disease: 2018 Update. Strategy 2.F: Ensure that People with Alzheimer's Disease and Related Dementias Experience Safe and Effective Transitions between Care Settings and Systems

People with AD/ADRD have higher rates of emergency room visits and hospitalizations, two settings where they are vulnerable to stress, delirium, and unnecessary complications. A transition between providers and care settings is a complex time of care delivery for all people, but especially for frail elders or other people with AD/ADRD who often ha

National Plan to Address Alzheimer's Disease: 2018 Update. Strategy 2.E: Explore the Effectiveness of New Models of Care for People with Alzheimer's Disease and Related Dementias

Work is underway at a number of agencies to identify models that provide more effective and efficient care for people with AD/ADRD. Models that improve health and quality of life for people eligible for both Medicaid and Medicare (dual eligibles) are also of great importance to the AD/ADRD population, as approximately 19% of the dual eligible popu

National Plan to Address Alzheimer's Disease: 2018 Update. Strategy 2.D: Identify High-Quality Dementia Care Guidelines and Measures Across Care Settings

Guidelines for delivery of high-quality care and measures of quality care are needed to ensure that people with AD/ADRD receive high-quality, culturally-competent care in the many different settings where they receive services. These guidelines and measures should be tailored to the stages of the disease, address the physical, cognitive, emotional

National Plan to Address Alzheimer's Disease: 2018 Update. Strategy 2.C: Educate and Support People with Alzheimer's Disease and Related Dementias and Their Families upon Diagnosis

Often, even though a physician or another health care provider has identified cognitive impairment, the patient and his or her family and caregivers are not told of the diagnosis. Further, once a diagnosis is made and disclosed, as few as half of patients and families receive counseling, support, or information about next steps. This information i

National Plan to Address Alzheimer's Disease: 2018 Update. Strategy 2.B: Ensure Timely and Accurate Diagnosis

Far too many people with AD/ADRD are not diagnosed until their symptoms have become severe. Timely diagnosis gives people with the condition and their families and caregivers time to plan and prepare for the future, leading to more positive outcomes for both. For some, the inability to access health care due to a lack of insurance or limited finan

National Plan to Address Alzheimer's Disease: 2018 Update. Strategy 2.A: Build a Workforce with the Skills to Provide High-Quality Care

The workforce that cares for people with AD/ADRD includes health care and LTSS providers such as primary care physicians; specialists such as neurologists, geriatricians, and psychiatrists; registered nurses and advanced practice nurses; community health workers; social workers; psychologists; pharmacists; dentists; allied health professionals; an

National Plan to Address Alzheimer's Disease: 2018 Update. Goal 2: Enhance Care Quality and Efficiency

Providing all people with AD/ADRD with the highest-quality care in the most efficient manner requires a multi-tiered approach. High-quality care requires an adequate supply of culturally-competent professionals with appropriate skills, ranging from direct care workers to community health and social workers to primary care providers and specialists

National Plan to Address Alzheimer's Disease: 2018 Update. Strategy 1.E: Facilitate Translation of Findings into Medical Practice and Public Health Programs

Currently, promising research and interventions are published in the research literature and presented at scientific meetings. Additional steps are needed to highlight promising findings and to facilitate dissemination and implementation of effective interventions to the general public, medical practitioners, the pharmaceutical industry, and publi

National Plan to Address Alzheimer's Disease: 2018 Update. Strategy 1.D: Coordinate Research with International Public and Private Entities

In order to facilitate communication and collaboration, build synergy, and leverage resources, it is imperative that research across nations and across funders be coordinated. The actions below will formalize the coordination process beyond HHS and the Federal Government and make research available to the public for input. ( UPDATED ) Action 1.

National Plan to Address Alzheimer's Disease: 2018 Update. Strategy 1.C: Accelerate Efforts to Identify Early and Presymptomatic Stages of Alzheimer's Disease and Related Dementias

Significant advances in the use of imaging and biomarkers in brain, blood, and spinal fluid have made it possible to detect the onset of AD/ADRD and track its progression, with the hope that it will be possible to monitor the effect of treatment in people with the disease. Without these advances, these neurodegenerative processes could only be eva

National Plan to Address Alzheimer's Disease: 2018 Update. Strategy 1.B: Expand Research Aimed at Preventing and Treating Alzheimer's Disease and Related Dementias

HHS and its federal partners will expand clinical trials on pharmacologic and non-pharmacologic ways to prevent AD/ADRD and manage and treat its symptoms. The Federal Government will address the challenge of enrolling enough people in clinical trials who are representative of the country's population, including racial and ethnic populations that a

National Plan to Address Alzheimer's Disease: 2018 Update. Strategy 1.A: Identify Research Priorities and Milestones

Research agencies undertake research planning processes on an ongoing basis, but a special effort is needed to identify the priorities and milestones to achieve Goal 1. The actions below will identify the priorities, establish milestones, and ensure that appropriate stakeholders are involved in the planning process aimed at minimizing AD/ADRD as a

National Plan to Address Alzheimer's Disease: 2018 Update. Goal 1: Prevent and Effectively Treat Alzheimer's Disease and Related Dementias by 2025

Research continues to expand our understanding of the causes of, treatments for, and prevention of AD/ADRD. This goal seeks to develop effective prevention and treatment modalities by 2025. Ongoing research and clinical inquiry can inform our ability to delay onset of AD/ADRD, minimize its symptoms, and delay its progression.

National Plan to Address Alzheimer's Disease: 2018 Update. Introduction

National Alzheimer's Project Act On January 4, 2011, the National Alzheimer's Project Act (NAPA) (Public Law 111-375) was signed into law. The Act defines "Alzheimer's" as Alzheimer's disease and related dementias (AD/ADRD) and requires the Secretary of the U.S. Department of Health and Human Services (HHS) to establish the National Alzheimer's

Advisory Council October 2018 Meeting Presentations: Panel 2

ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES Friday, October 19, 2018 Printer Friendly Version in PDF Format (24 PDF pages) Panel 2: Managing Behavioral Symptoms of AD/ADRD Michelle Dionne-Vahalik Laura Gitlin

Advisory Council October 2018 Meeting Presentations: Panel 1

ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES Friday, October 19, 2018 Printer Friendly Version in PDF Format (11 PDF pages) Panel 1: When Dementia is Different: Meeting the LTSS Needs of a Heterogeneous Population Katie Brandt Cynthia Huling Hummel

Advisory Council October 2018 Meeting Agenda

AGENDA Advisory Council on Alzheimer's Research, Care, and Services October 19, 2018 9:00 am - 5:00 pm (Eastern Time) Streamed live -- http://www.hhs.gov/live U.S. Department of Health and Human Services 200 Independence Avenue, S.W. Room 800, H.H. Humphrey Building Washington, DC 20201

Advisory Council October 2018 Meeting Announcement

Advisory Council October 2018 Meeting Announcement Printer Friendly Version in PDF Format (1 PDF pages)

Advisory Council July 2018 Meeting Summary

ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES July 30, 2018 Washington, DC Printer Friendly Version in PDF Format (24 PDF pages)

Content by Keyword: Dementia and Alzheimer's Disease